ArticleEClinicalMedicine2026

Comparative efficacy and safety of four long-acting granulocyte colony-stimulating factors for primary prophylaxis in patients with breast cancer: a prospective observational cohort study in China.

Zihan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.